Literature DB >> 28755024

Concentration of acute phase factors in vitreous fluid in diabetic macular edema.

Kazuhiro Kimura1, Tomoko Orita2, Yuka Kobayashi2, Shigeo Matsuyama3, Kazushi Fujimoto4, Kazuhiko Yamauchi5.   

Abstract

PURPOSE: Diabetic retinal maculopathy is associated with acute and chronic local inflammation. We measured the concentrations of acute phase factors in vitreous fluid of patients with diabetic macular edema (DME) and examined their relations to visual acuity and central retinal thickness (CRT) both before and after vitrectomy. STUDY
DESIGN: Retrospective.
METHODS: Vitreous fluid was collected during vitreoretinal surgery from 19 patients with DME and 12 control subjects with epiretinal membrane. The concentrations of acute phase factors (α2-macroglobulin, haptoglobin, C-reactive protein, serum amyloid P and A, procalcitonin, ferritin, tissue plasminogen activator, fibrinogen) and vascular endothelial growth factor (VEGF) were measured with multiplex assays. CRT of macular edema was measured by optical coherence tomography (OCT).
RESULTS: The levels of serum amyloid P, procalcitonin, ferritin, and fibrinogen in vitreous fluid were increased in DME patients compared with control subjects. The levels of procalcitonin and fibrinogen in DME patients were inversely correlated with visual acuity both before and 3 months after vitrectomy but not 6 months postsurgery. The concentrations of these four factors were not correlated with either CRT or the vitreous levels of VEGF in DME patients.
CONCLUSION: Acute phase factors may contribute to local inflammation in DME and may therefore influence disease progression.

Entities:  

Keywords:  Acute phase factor; Central retinal thickness; Diabetic macular edema; Vascular endothelial growth factor (VEGF); Visual acuity

Mesh:

Substances:

Year:  2017        PMID: 28755024     DOI: 10.1007/s10384-017-0525-x

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  24 in total

Review 1.  Diabetic Macular Edema: Pathophysiology and Novel Therapeutic Targets.

Authors:  Arup Das; Paul G McGuire; Sampathkumar Rangasamy
Journal:  Ophthalmology       Date:  2015-04-30       Impact factor: 12.079

2.  Role of inflammation in diabetic macular edema.

Authors:  Hidetaka Noma; Tatsuya Mimura; Kanako Yasuda; Masahiko Shimura
Journal:  Ophthalmologica       Date:  2014-10-18       Impact factor: 3.250

3.  Intraocular expression of serum amyloid a and interleukin-6 in proliferative diabetic retinopathy.

Authors:  Yan Ma; Yong Tao; Qiang Lu; Yan-Rong Jiang
Journal:  Am J Ophthalmol       Date:  2011-06-25       Impact factor: 5.258

4.  Changes in aqueous concentrations of various cytokines after intravitreal triamcinolone versus bevacizumab for diabetic macular edema.

Authors:  Hee Jin Sohn; Dae Heon Han; Im Tae Kim; In Kyung Oh; Kyun Hyung Kim; Dae Yeong Lee; Dong Heun Nam
Journal:  Am J Ophthalmol       Date:  2011-07-22       Impact factor: 5.258

Review 5.  Role of cytokines, acute-phase proteins, and chemokines in the progression of rheumatoid arthritis.

Authors:  R Badolato; J J Oppenheim
Journal:  Semin Arthritis Rheum       Date:  1996-10       Impact factor: 5.532

Review 6.  Vascular endothelial growth factors and angiogenesis in eye disease.

Authors:  A N Witmer; G F J M Vrensen; C J F Van Noorden; R O Schlingemann
Journal:  Prog Retin Eye Res       Date:  2003-01       Impact factor: 21.198

7.  Clinical practice pattern in management of diabetic macular edema in Japan: survey results of Japanese retinal specialists.

Authors:  Yuichiro Ogura; Fumio Shiraga; Hiroko Terasaki; Masahito Ohji; Susumu Ishida; Taiji Sakamoto; Akito Hirakata; Tatsuro Ishibashi
Journal:  Jpn J Ophthalmol       Date:  2016-10-08       Impact factor: 2.447

Review 8.  Cardiac effects of chronic inflammation in dialysis patients.

Authors:  Antonio Santoro; Elena Mancini
Journal:  Nephrol Dial Transplant       Date:  2002       Impact factor: 5.992

9.  Vascular complications and diabetes: current therapies and future challenges.

Authors:  Abbott L Willard; Ira M Herman
Journal:  J Ophthalmol       Date:  2012-01-09       Impact factor: 1.909

Review 10.  Molecular mechanisms of diabetic retinopathy: potential therapeutic targets.

Authors:  Maha Coucha; Sally L Elshaer; Wael S Eldahshan; Barbara A Mysona; Azza B El-Remessy
Journal:  Middle East Afr J Ophthalmol       Date:  2015 Apr-Jun
View more
  1 in total

Review 1.  Intraocular fluid biomarkers (liquid biopsy) in human diabetic retinopathy.

Authors:  Edoardo Midena; Luisa Frizziero; Giulia Midena; Elisabetta Pilotto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-07-03       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.